Discover 158 paid clinical trials in Reno, Nevada. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 158
Active & Responsive
Helix Research Network
for
Genetic Predisposition to Disease, Genetics Disease
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Reno NV, Dallas TX, La Crosse WI, Carmel IN
Sponsor: Complement Therapeutics
Sex: All
Age: 55+
Code: NCT07392255
Phase 1, Phase 2, Recruiting
Active & Responsive
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Reno NV, Dallas TX, La Crosse WI, Springfield IL,
Sponsor: Complement Therapeutics
Sex: All
Age: 55+
Code: NCT07144137
Recruiting
Active & Responsive
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
for
Geographic Atrophy
Location: Reno NV, Sacramento CA, San Francisco CA,
Sponsor: Genentech, Inc.
Sex: All
Age: 50+
Code: NCT05626114
Phase 2, Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Reno NV, Roseville CA, Sacramento CA, Santa Rosa CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Reno NV, San Francisco CA, Boise ID, Las Vegas NV,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Reno NV, Salt Lake City UT, San Diego CA, Tucson AZ,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05216432
Phase 1, Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Location: Reno NV, Riverside CA, Salt Lake City UT, Phoenix AZ,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT06911632
Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Reno NV, Roseville CA, Stockton CA, Walnut Creek CA,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase 3, Recruiting
Active & Responsive
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
for
Hypertension
Location: Reno NV, Palo Alto CA, Los Angeles CA,
Sponsor: SoniVie Inc.
Sex: All
Age: 22 - 70+
Code: NCT06559891
Recruiting
Active & Responsive
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
for
Cutaneous Melanoma
Location: Reno NV, Rocklin CA, Carmichael CA, Sacramento CA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 70+
Code: NCT07068074
Phase 3, Recruiting
Active & Responsive
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
for
Idiopathic Pulmonary Fibrosis (IPF)
Location: Reno NV, Redding CA, Palm Spring CA, El Paso TX,
Sponsor: PureTech
Sex: All
Age: 40+
Code: NCT07284602
Phase 3, Recruiting
Active & Responsive
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
for
Lung Cancer Diagnosis
Location: Reno NV, Los Angeles CA, Portland OR, Houston TX,
Sponsor: Freenome Holdings Inc.
Sex: All
Age: 50+
Code: NCT06122077
Recruiting
Active & Responsive
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
for
Metastatic Breast Cancer
Location: Reno NV, Los Angeles CA, Duarte CA, Irvine CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT03424005
Phase 1, Phase 2, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Reno NV, Sacramento CA, Vallejo CA, San Francisco CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: Reno NV, Sacramento CA, Seattle WA, Billings MT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase 3, Recruiting
Active & Responsive
The Social Regulation of Threat-related Vigilance and Arousal
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Reno NV, Fremont CA, Northridge CA, Los Angeles CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Phase 4, Recruiting
Active & Responsive
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
for
Migraine
Location: Reno NV, Los Angeles CA, Pomona CA, Ogden UT,